EU Approves Celera's HCV Genotyping Test | GenomeWeb
NEW YORK (GenomeWeb News) – The Europen Union awarded the CE Mark to Celera Genomics' hepatitis C virus genotyping test, parent Applera said today.
 
Celera developed the RealTime HCV Genotype Assay with Abbott. It will be sold as part of this alliance. The test is designed to be used on Applied Biosystems' PRISM 7000 PCR system.
 
Called the Abbott RealTime HCV Genotype test, it complements the HCV quantitative viral load test available on Abbott’s m2000 system.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.